in cold distilled water. After filtered through 70-µm nylon mesh and counting
using a MACSQuant analyzer (Miltenyi Biotec), cells were incubated with anti-CD16/32
antibody (Bio X Cell) to block Fc receptors and stained with fixable viability dye eFluor
780 (eBioscience). Cells were then stained for 20 min in staining media (Hank’s
balanced salt solution, 3% FBS, 0.02% sodium azide, 1 mM EDTA) with
primary antibodies including B220-FITC, B220-eVolve 655 (clone RA3–6B2),
GL7-eFluor 660, GL7-eFluor 450 (clone GL7), CD95-PE, CD95-APC (clone 15A7) (eBioscience),
peanut agglutinin (PNA)-biotin (Vector Laboratories), CD86-Pe-Cy7 (clone GL-1; BioLegend)
or CD184-biotin (2b11/CXCR4; BD Biosciences). Cells stained with biotin-labeled antibodies
were incubated with streptavidin-eFluor 450 (eBioscience). For intracellular staining,
cells were stained with fixable viability dye eFluor 780, permeabilized and fixed using a
cytofix/cytoperm plus kit (BD Biosciences) according to manufacturer suggested protocol.
Cells were then stained with YY1 antibody (H-414; Santa Cruz Biotechnology) and DyLight
594-conjugated secondary antibody (Jackson ImmunoResearch). Flow cytometry analysis was
performed on an LSRII FACS or a FACSAria cell sorter (BD Biosciences), and analyzed using
FlowJo software (FlowJo).